back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-28,325 vol |
73,270 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-264,366
-14,687 vol $18.00 each |
36,413 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$509,850
+28,325 vol $18.00 each |
51,100 | |
| Filed 2016-11-14 Tx date 2016-11-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$18,023
+817 vol $22.06 each |
||
| Filed 2016-11-14 Tx date 2016-11-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-18,023.02
-817 vol $22.06 each |
22,775 | |
| Filed 2016-11-10 Tx date 2016-11-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$18,023
+817 vol $22.06 each |
24,409 | |
| Filed 2016-11-10 Tx date 2016-11-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,575 vol |
101,595 | |
| Filed 2016-11-10 Tx date 2016-11-04 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$34,744
+1,575 vol $22.06 each |
23,592 | |
| Filed 2016-08-12 Tx date 2016-08-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,580 vol |
23,355 | |
| Filed 2016-08-12 Tx date 2016-07-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,580 vol |
||
| Filed 2016-08-12 Tx date 2016-08-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,338 vol |
||
| Filed 2016-08-12 Tx date 2016-08-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-31,496.52
-1,338 vol $23.54 each |
22,017 | |
| Filed 2016-08-12 Tx date 2016-07-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,580 vol |
||
| Filed 2016-08-12 Tx date 2016-08-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,580 vol |
103,170 | |
| Filed 2016-05-16 Tx date 2016-05-12 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$2,118,426
+84,975 vol $24.93 each |
105,750 | |
| Filed 2015-10-22 Tx date 2015-10-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,155,577
+7,875 vol $146.74 each |
20,775 | |
| Filed 2015-08-04 Tx date 2015-07-31 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$181,104
+704 vol $257.25 each |
20,775 | |
| Filed 2015-08-04 Tx date 2015-07-31 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$181,104
+704 vol $257.25 each |
||
| Filed 2015-08-03 Tx date 2015-07-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,821,362
+7,171 vol $253.99 each |
20,071 | |
| Filed 2015-08-03 Tx date 2015-07-31 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$181,104
+704 vol $257.25 each |
20,775 | |
| Filed 2015-07-22 Tx date 2015-06-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-22 Tx date 2015-07-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,094,452
+12,900 vol $239.88 each |
12,900 | |
| Filed 2015-07-02 Tx date 2015-06-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-02 Tx date 2015-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$93,121,920
+408,000 vol $228.24 each |
408,000 | |
| Filed 2015-06-16 Tx date 2015-06-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-16 Tx date 2015-06-12 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Rosiello, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,999,379
+12,900 vol $232.51 each |
12,900 |